UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Follow‐up of SARS‐CoV‐2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study

Journal of medical virology, 2021-05, Vol.93 (5), p.2925-2931

2021

Volltextzugriff (PDF)

Safety of drotrecogin alfa (activated) in severe sepsis: Data from adult clinical trials and observational studies

Journal of critical care, 2009-12, Vol.24 (4), p.595-602

2009

Volltextzugriff (PDF)

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1493-1497

2019

Volltextzugriff (PDF)

A prospective, observational study of Xigris Use in the United States (XEUS)

Journal of critical care, 2010-12, Vol.25 (4), p.660.e9-660.e16

2010

Volltextzugriff (PDF)

Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-World Setting

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin

Diabetes, obesity & metabolism, 2019-09, Vol.21 (9), p.2048-2057

2019

Volltextzugriff (PDF)

Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

A cross‐sectional community‐based observational study of asymptomatic SARS‐CoV‐2 prevalence in the greater Indianapolis area

Journal of medical virology, 2020-11, Vol.92 (11), p.2874-2879

2020

Volltextzugriff (PDF)

233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting

Clinical therapeutics, 2018-08, Vol.40 (8), p.1396-1407

2018

Volltextzugriff (PDF)

Efficacy and Safety of an Expanded Dulaglutide Dose Range—A Phase 2, Placebo-Controlled Trial in T2D Patients on Metformin

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population

Diabetes therapy, 2018-04, Vol.9 (2), p.637-650

2018

Volltextzugriff (PDF)

OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

Durability of Response Following Cessation of Tadalafil Taken Once Daily as Treatment for Erectile Dysfunction

Journal of sexual medicine, 2010-10, Vol.7 (10), p.3487-3494

2010

Volltextzugriff (PDF)

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

Journal of intensive care medicine, 2011-01, Vol.26 (1), p.34-40

2011

Volltextzugriff (PDF)

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial

Critical care medicine, 2008-01, Vol.36 (1), p.14-23

2008

Volltextzugriff (PDF)

BASELINE CHARACTERISTICS OF PATIENTS ENROLLED IN RESOLVE: A PHASE III TRIAL OF DROTRECOGIN ALFA (ACTIVATED) IN PEDIATRIC SEVERE SEPSIS: 176-T

Critical care medicine, 2005-12, Vol.33, p.A154

2005

Volltextzugriff (PDF)

FCC Fines Radio Stations for Minority Hiring Policies

Billboard, 1989-09, Vol.101 (36), p.87

Woodward, Brad

1989

Volltextzugriff (PDF)

Beware of these Xigris dosing concerns

Drug topics, 2006-10, Vol.150 (20), p.HSE10

Woodward, Brad

2006

Volltextzugriff (PDF)

Radio: FCC Pieces Fall Into Place With Swearings-ln, Staff Picks

Billboard (Cincinnati, Ohio. 1963), 1989-09, Vol.101 (35), p.11

Woodward, Brad

1989

Volltextzugriff (PDF)

Rep. Leland was a champion of minority broadcast issues

Billboard, 1989-08, Vol.101 (34), p.14

Woodward, Brad

1989

Volltextzugriff (PDF)

Radio: Rep. Leland Was A Champion Of Minority Broadcast Issues

Billboard (Cincinnati, Ohio. 1963), 1989-08, Vol.101 (34), p.14

Woodward, Brad

1989

Volltextzugriff (PDF)

Radio: WASHINGTON ROUNDUP

Billboard (Cincinnati, Ohio. 1963), 1989-08, Vol.101 (33), p.10

Woodward, Brad

1989

Volltextzugriff (PDF)

Ecophysiological traits in C₃ and C₄ grasses: a phylogenetically controlled screening experiment

The New phytologist, 2010-02, Vol.185 (3), p.780-791

2010

Volltextzugriff (PDF)

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1746-1755

2019

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(32)
Humans
(29)
Male
(19)
Middle Aged
(19)
Aged
(17)
Female
(17)
Biological And Medical Sciences
(13)
Glomerular Filtration Rate
(13)
Risk Factors
(13)
Medical Sciences
(11)
Proportional Hazards Models
(10)
Adult
(9)
Kidney Diseases
(8)
Nephrology. Urinary Tract Diseases
(8)
Prognosis
(8)
Urology & Nephrology
(8)
Diabetes
(7)
Disease Progression
(7)
Kidney Failure, Chronic - Physiopathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Billboard
(5)
Kidney International
(5)
Diabetes
(4)
Newsweek
(4)
Circulation
(3)
Global Change Biology
(3)
Journal Of The American Society Of Nephrology
(3)
The Lancet
(3)
Critical Care Medicine
(2)
Diabetes, Obesity & Metabolism
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Follow‐up of SARS‐CoV‐2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study

Safety of drotrecogin alfa (activated) in severe sepsis: Data from adult clinical trials and observational studies

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)

A prospective, observational study of Xigris Use in the United States (XEUS)

Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-World Setting

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin

Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

A cross‐sectional community‐based observational study of asymptomatic SARS‐CoV‐2 prevalence in the greater Indianapolis area

233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting

Efficacy and Safety of an Expanded Dulaglutide Dose Range—A Phase 2, Placebo-Controlled Trial in T2D Patients on Metformin

Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population

OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Durability of Response Following Cessation of Tadalafil Taken Once Daily as Treatment for Erectile Dysfunction

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial

BASELINE CHARACTERISTICS OF PATIENTS ENROLLED IN RESOLVE: A PHASE III TRIAL OF DROTRECOGIN ALFA (ACTIVATED) IN PEDIATRIC SEVERE SEPSIS: 176-T

FCC Fines Radio Stations for Minority Hiring Policies

Beware of these Xigris dosing concerns

Radio: FCC Pieces Fall Into Place With Swearings-ln, Staff Picks

Rep. Leland was a champion of minority broadcast issues

Radio: Rep. Leland Was A Champion Of Minority Broadcast Issues

Radio: WASHINGTON ROUNDUP

Ecophysiological traits in C₃ and C₄ grasses: a phylogenetically controlled screening experiment

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data

Suchergebnisse filtern